Inappropriate prescribing of combination inhalers in Northern Ireland: Retrospective cross-sectional cohort study of prescribing practice in primary care

Primary Care Respiratory Journal

Volumn 23, Issue 1, 2014, Pages 74-78

  Sweeney, Joan ^a   Patterson, Chris C ^a   O'Neill, Stephen ^b   O'Neill, Ciaran ^b   Plant, Gillian ^c   Lynch, Veranne ^c   McAllister, Teresa ^c   Heaney, Liam G ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^c HEALTH AND SOCIAL CARE BOARD   (United Kingdom)

Author keywords

Asthma; Asthma guidelines; Asthma in primary care

Indexed keywords

ANTIBIOTIC AGENT; BECLOMETASONE DIPROPIONATE PLUS FORMOTEROL FUMARATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE PLUS FORMOTEROL; CORTICOSTEROID; FLUTICASONE PROPIONATE PLUS SALMETEROL XINAFOATE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LONG ACTING BETA 2 AGONIST; SHORT ACTING BETA 2 AGONIST; STEROID; UNCLASSIFIED DRUG; ANTIASTHMATIC AGENT;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CHILD; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; CROSS-SECTIONAL STUDY; DISEASE EXACERBATION; HUMAN; INAPPROPRIATE PRESCRIBING; IRELAND; MAJOR CLINICAL STUDY; MONOTHERAPY; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; RETROSPECTIVE STUDY; DRUG COMBINATION; NEBULIZER; PRESCHOOL CHILD; PRIMARY HEALTH CARE; STATISTICS AND NUMERICAL DATA; UNITED KINGDOM; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; GUIDELINE ADHERENCE; HUMANS; INAPPROPRIATE PRESCRIBING; NEBULIZERS AND VAPORIZERS; NORTHERN IRELAND; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84895174643     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.4104/pcrj.2014.00007     Document Type: Article

References (11)

1. British Thoracic Society/Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma-a national clinical guideline. Revised January 2012. Available from http://www.brit-thoracic.org.uk/guidelines/asthma-guidelines.aspx
2. National Institute for Health and Clinical Excellence. Inhaled corticosteroids for the treatment of chronic asthma in adults and in children aged 12 years and over. NICE Technology Appraisal Guidance 138, 2008.
3. HSC Prescription Cost Analysis for Northern Ireland 2010. http://www.hscbusiness.hscni.net/services/1806.htm
4. NHS Information Centre, Prescription Cost Analysis England, 2011. http://www.ic.nhs.uk/searchcatalogue?productid=5461&q=title%3a%22prescriptio n+cost+analysis%22&sort=Relevance&size=10&page=1#top
5. Welsh Government, Prescription Cost Analysis Wales, 2011. http://wales.gov.uk/topics/statistics/headlines/health2012/1203281/?lang=en
6. Information Services Division, Prescription Cost Analysis Scotland, 2011. http://www.isdscotland.org/Health-Topics/Prescribing-and-Medicines/Community-Dispensing/Prescription-Cost-Analysis/
7. Thomas M, Murray-Thomas T, Fan T, Williams T, Taylor, S. Prescribing patterns of asthma controller therapy for children in UK primary care: a cross-sectional observational study. BMC Pulm Med 2010;10:29. http://dx.doi.org/10.1186/1471-2466-10-29
8. Friedman HS, Eid NS, Crespi S, Wilcox TK, Reardon G. Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations. Clin Ther 2009;31:1056-63. http://dx.doi.org/10.1016/j.clinthera.2009.05.008
9. Breton MC, Lelorier J, Forget A, Blais L. Use of combination therapy in asthma: are they prescribed according to guidelines. Respir Med 2007;101:1916-23. http://dx.doi.org/10.1016/j.rmed.2007.04.017
10. Bianchi M, Clavenna A, Sequi M, et al. Anti-asthma medication prescribing to children in the Lombardy region of Italy: chronic versus new users. BMC Pulm Med 2011;11:48. http://dx.doi.org/10.1186/1471-2466-11-48
11. Health and Social Care Board. Asthma: keeping in STEP with the guidelines. Northern Ireland Medicines Management Newsletter 2012;3(4):Supplement. http://www.hscboard.hscni.net/medicinesmanagement/Medicines%20Management %20Newsletter/Volume%2003/004%20Issue%204%20-%20Special%20 Supplement.pdf